Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard I Shader

Showing results (71-80 of 187) with videos related to

Pageof 19
Sort By:
Journal of Clinical Psychopharmacology|December 21, 2020
James (Jeff) Walter Jefferson, MDRichard I Shader
Clinical Therapeutics|June 27, 2017
Drug Safety, Climate Change, Causality, and PredictabilityRichard I Shader
Journal of Clinical Psychopharmacology|September 29, 2025
Question: Does Cinnamon Interfere With Antidepressant Metabolism?Richard I Shader
Journal of Clinical Psychopharmacology|August 16, 2003
Antagonists, inverse agonists, and protagonistsRichard I Shader
Journal of Clinical Psychopharmacology|June 27, 2003
Foods, genetics, and drug interactionsRichard I Shader
Clinical Therapeutics|February 11, 2020
A Note from the Editor-in-Chief Emeritus: A Reluctant Farewell to Clinical TherapeuticsRichard I Shader
Clinical Therapeutics|December 15, 2018
Pharmacovigilance and Some Thoughts About What We EatRichard I Shader
Clinical Therapeutics|December 27, 2017
Adherence Measurements in Clinical Trials and CareRichard I Shader
Clinical Therapeutics|December 17, 2013
Reflections on 2013, the beginning of 2014, and the Food and Drug Administration's new expedited approval program known as breakthrough product designationRichard I Shader
Journal of Clinical Psychopharmacology|August 7, 2016
The Ten Cs of Good Clinical CareRichard I Shader
Pageof 19

Showing results (71-80 of 187) with videos related to

Sort By:
Pageof 19
Journal of Clinical Psychopharmacology|December 21, 2020
James (Jeff) Walter Jefferson, MDRichard I Shader
Clinical Therapeutics|June 27, 2017
Drug Safety, Climate Change, Causality, and PredictabilityRichard I Shader
Journal of Clinical Psychopharmacology|September 29, 2025
Question: Does Cinnamon Interfere With Antidepressant Metabolism?Richard I Shader
Journal of Clinical Psychopharmacology|August 16, 2003
Antagonists, inverse agonists, and protagonistsRichard I Shader
Journal of Clinical Psychopharmacology|June 27, 2003
Foods, genetics, and drug interactionsRichard I Shader
Clinical Therapeutics|February 11, 2020
A Note from the Editor-in-Chief Emeritus: A Reluctant Farewell to Clinical TherapeuticsRichard I Shader
Clinical Therapeutics|December 15, 2018
Pharmacovigilance and Some Thoughts About What We EatRichard I Shader
Clinical Therapeutics|December 27, 2017
Adherence Measurements in Clinical Trials and CareRichard I Shader
Clinical Therapeutics|December 17, 2013
Reflections on 2013, the beginning of 2014, and the Food and Drug Administration's new expedited approval program known as breakthrough product designationRichard I Shader
Journal of Clinical Psychopharmacology|August 7, 2016
The Ten Cs of Good Clinical CareRichard I Shader
Pageof 19